Since its foundation in 2008, Ampio Pharmaceuticals (NYSE: AMPE) has been focused on delivering a drug that treats inflammation caused by a
Covid vaccine won’t dent Ampio Pharma’s market: CEO Michael Macaluso
Categories
Interviews
No negative impact from server price hike, says Alteryx CFO
Unlike prior years, 2020 has been a particularly difficult year on the bourses for Alteryx, Inc. (NYSE: AYX). The stock kept bouncing
Recovery in credit demand, consumer confidence will drive growth: 360 DigiTech CFO Alex Xu
Encouraged by the strong performance of its capital-light business, 360 DigiTech, Inc. (NASDAQ: QFIN) is transitioning into a low-risk business model. The
Usio: An under-the-radar fintech firm
Value investors have long viewed the fintech industry as a gold mine of opportunities in the years to come, with payment processing
Current focus is on scaling up capabilities: 10x Genomics CEO Serge Saxonov
10x Genomics, Inc. (NASDAQ: TXG), a pioneer in single-cell genomics, has been eliciting significant investor interest ever since it went public more
WiSA optimism driven by new product launches: Summit Wireless CEO
Despite being a micro-cap player, Summit Wireless Technologies (NASDAQ: WISA) shook the market after posting third-quarter financial results earlier this week. The
SingleCare deal aimed at growing subscribers: Trxade CEO Suren Ajjarapu
Trxade (NASDAQ: MEDS) may have been on a dream run of late due to the strong demand for PPE, but the drug
Committed to helping advertisers scale customer base: DMS CEO Joe Marinucci
With cyberspace rapidly emerging as the preferred platform for marketing, result-oriented advertisers are gradually shifting their focus from clicks and impressions to
Stimulus to PPP: Five questions to Washington Trust (WASH) management
On the heels of relatively strong earnings performance by major banks driven by lower allowance to credit losses and stronger-than-expected trading, Washington
Loop Industries: Tapping into infinite plastic recycling
According to a recent study, global plastic consumption is estimated to be about 710 million metric tons within the next two decades
Astec Industries is coming out of COVID-19 as a stronger company: CEO Barry Ruffalo
One of the best ways to find promising stocks is by identifying firms that have outperformed the industry during periods of weakness.
Applied UV eyes an untapped global market
Healthcare-associated infection (HAI) is among the worst under-reported health hazards across the globe. According to recent studies, about one in 25 patients
Worthington Industries CFO stays cautious despite recovery in steel demand
The past few months have been quite challenging for manufacturing companies, and the story of Worthington Industries (NYSE: WOR) was no different.
Boomer Naturals: Hitting the bull’s eye during the pandemic
So far this year, we have witnessed how companies have adapted to the new normal of the pandemic lifestyle to drive business.
NovoCure (NVCR): Why this medtech firm matters
Even as COVID-19 is wreaking havoc across the world, cancer continues to kill about 10 million people per year, and the quest
New name better illustrates 360 Finance’s long-term strategy: CFO Alex Xu
360 Finance, Inc. (NASDAQ: QFIN) is all set to assume a new identity this year, continuing its transformation into a uniquely innovative
Resonant is probably the 5G stock you have been looking for
5G is undeniably the next big thing that is set to revolutionize the tech industry. According to a recent study, the 5G
How Mohawk Group is creating a cocktail of tech-enabled consumer brands
When Amazon (NASDAQ: AMZN) combined the capabilities of technology and retail a few years ago, what followed was a revolutionary shift in
Oncology to COVID-19: Karyopharm (KPTI) CEO on what’s ahead
The oncology research space has become rather crowded these days, with numerous clinical-level companies cropping up with novel technologies. While these offer
No concerns on margin side: Trxade (MEDS) CEO Suren Ajjarapu
A lot is being spoken and written about Amazon (NASDAQ: AMZN), Shopify (NYSE: SHOP) and JD.com (NASDAQ: JD) and their prospects in
With IP valued at $34 million, C-Bond Systems offers an unbreakable deal
C-Bond Systems (OTC: CBNT), founded in 2007, is a nanotechnology solutions firm focused at giving glass and other brittle materials better longevity